Results: 1-25 | 26-50 | 51-67

Table of contents of journal: *Cancer biotherapy & radiopharmaceuticals

Results: 1-25/67

Authors: DeNardo, GL Oldham, RK
Citation: Gl. Denardo et Rk. Oldham, Banner Millennium 2000 year for CB&R and Mary Ann Liebert, CANC BIO R, 15(6), 2000, pp. 527-528

Authors: Khazaeli, MB
Citation: Mb. Khazaeli, Quality control of radiolabeled monoclonal antibodies, CANC BIO R, 15(6), 2000, pp. 529-530

Authors: Cutler, CS Smith, CJ Ehrhardt, GJ Tyler, TT Jurisson, SS Deutsch, E
Citation: Cs. Cutler et al., Current and potential therapeutic uses of lanthanide radioisotopes, CANC BIO R, 15(6), 2000, pp. 531-545

Authors: DeNardo, GL DeNardo, SJ Wessels, BW Kukis, DL Miyao, N Yuan, AN
Citation: Gl. Denardo et al., I-131-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors:Loss of tumor specificity due to radiolysis, CANC BIO R, 15(6), 2000, pp. 547-560

Authors: Haigh, PI Glass, EC Essner, R
Citation: Pi. Haigh et al., Accuracy of gamma probes in localizing radioactivity: In-vitro assessment and clinical implications, CANC BIO R, 15(6), 2000, pp. 561-569

Authors: Illidge, T Honeychurch, J Howatt, W Ross, F Wilkins, B Cragg, M
Citation: T. Illidge et al., A new in vivo and in vitro B cell lymphoma model, pi-BCL1, CANC BIO R, 15(6), 2000, pp. 571-580

Authors: Illidge, T Honeychurch, J Vandersteen, A Cragg, M
Citation: T. Illidge et al., Radioimmunotherapy in the pi-BCL1 B cell lymphoma model: Efficacy depends on more than targeted irradiation alone, CANC BIO R, 15(6), 2000, pp. 581-591

Authors: Lewis, JS Laforest, R Lewis, MR Anderson, CJ
Citation: Js. Lewis et al., Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogs in a tumor-bearing rat model, CANC BIO R, 15(6), 2000, pp. 593-604

Authors: Gaikwad, SY Jagtap, AG Ingle, AD Ra, SGA Gude, RP
Citation: Sy. Gaikwad et al., Antimetastatic efficacy of niosomal pentoxifylline and its combination with activated macrophages in murine B16F10 melanoma model, CANC BIO R, 15(6), 2000, pp. 605-615

Authors: Ferle-Vidovic, A Potjak-Blazi, M Rapic, V Skare, D
Citation: A. Ferle-vidovic et al., Ferrocenes (F168, F169) and fero-sorbitol-citrate (FSC): Potential anticancer drugs, CANC BIO R, 15(6), 2000, pp. 617-624

Authors: Suzuki, M Saga, Y Tsukagoshi, S Tamura, N Sato, I
Citation: M. Suzuki et al., Recurrent ovarian clear cell carcinoma: Complete remission after radiationin combination with hyperthermia; A case study and in vitro study, CANC BIO R, 15(6), 2000, pp. 625-628

Authors: Wimer, BM Mann, PL
Citation: Bm. Wimer et Pl. Mann, Mitogen immunotherapy for HIV infections exemplified by phytohemagglutininand pokeweed mitogen, CANC BIO R, 15(6), 2000, pp. 629-644

Authors: Stubbs, JB Strickland, AD Frank, RK Simon, J McMillan, K Williams, JA
Citation: Jb. Stubbs et al., Biodistribution and dosimetry of an aqueous solution containing sodium 3-(I-125)iodo-4-hydroxybenzenesulfonate (Iotrex (TM)) for brachytherapy of resected malignant brain tumors, CANC BIO R, 15(6), 2000, pp. 645-656

Authors: Blahd, WH
Citation: Wh. Blahd, Benedict Cassen: The father of body organ imaging - Historical vignette, CANC BIO R, 15(5), 2000, pp. 423-429

Authors: Vriesendorp, HM Quadri, SM
Citation: Hm. Vriesendorp et Sm. Quadri, Radiolabeled immunoglobulin therapy in patients with Hodgkin's disease, CANC BIO R, 15(5), 2000, pp. 431-445

Authors: Hnatowich, DJ
Citation: Dj. Hnatowich, Antisense imaging: Where are we now?, CANC BIO R, 15(5), 2000, pp. 447-457

Authors: Frankel, AE Sievers, EL Scheinberg, DA
Citation: Ae. Frankel et al., Cell surface receptor-targeted therapy of acute myeloid leukemia: A review, CANC BIO R, 15(5), 2000, pp. 459-476

Authors: Friedl, J Stift, A Paolini, P Roth, E Steger, GG Mader, R Jakesz, R Gnant, MFX
Citation: J. Friedl et al., Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer, CANC BIO R, 15(5), 2000, pp. 477-486

Authors: Dillman, RO Soori, G Wiemann, MC Schulof, R Dobbs, TW Ruben, RH DePriest, CB Church, C
Citation: Ro. Dillman et al., Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: Final results of Cancer Biotherapy Research Group94-11, CANC BIO R, 15(5), 2000, pp. 487-494

Authors: Jiang, XP Yang, DC Elliott, RL Head, JF
Citation: Xp. Jiang et al., Vaccination with a mixed vaccine of autogenous and allogeneic breast cancer cells and tumor associated antigens CA15-3, CEA and CA125 - Results in immune and clinical responses in breast cancer patients, CANC BIO R, 15(5), 2000, pp. 495-505

Authors: Rosebrough, SF Hartley, DF
Citation: Sf. Rosebrough et Df. Hartley, Isothiocyanate-trigalactose: Application for antibody-targeted delivery ofdiagnostic and therapeutic agents, CANC BIO R, 15(5), 2000, pp. 507-515

Authors: Forster, GJ Krummenauer, F Nickel, O Kahaly, GJ
Citation: Gj. Forster et al., Somatostatin-receptor scintigraphy in Graves' disease: Reproducibility andvariance of orbital activity, CANC BIO R, 15(5), 2000, pp. 517-525

Authors: Williams, LE
Citation: Le. Williams, Clinical results and the necessity of estimating patient-specific radiation absorbed dose in radioimmunotherapy, CANC BIO R, 15(4), 2000, pp. 301-303

Authors: Sisson, JC
Citation: Jc. Sisson, Radiopharmaceuticals for nuclear endocrinology at the University of Michigan, CANC BIO R, 15(4), 2000, pp. 305-318

Authors: Jurcic, JG
Citation: Jg. Jurcic, Antibody therapy of acute myelogenous leukemia, CANC BIO R, 15(4), 2000, pp. 319-326
Risultati: 1-25 | 26-50 | 51-67